S1400730

ABC60+DTG5+3TC30mg disp.tab/PAC180 NoCTN


Abacavir (as Sulfate) 60mg + Dolutegravir (as Sodium) 5mg and Lamivudine 30 mg dispersible tablets/ tablets for oral suspension in a fixed dose combination in a jar pack of 180 0 without outer carton includes patient information leaflet.
Indicative Price 15.40 USD
Disclaimer: The images shown are for illustration purposes only and may not be an exact representation of the product. “No Generic Photo Available" means that there is not an image available for this product.

General description:
Abacavir (as Sulfate) 60mg + Dolutegravir (as Sodium) 5mg and Lamivudine 30mg dispersible tablets/tablets for oral suspension in a fixed dose combination in a jar pack of 180 without outer carton, includes patient information leaflet.

Technical specification:
Each dispersible tablet/tablet for oral suspension contains Abacavir Sulfate equivalent to 60mg Abacavir plus Dolutegravir 5mg plus Lamivudine 30mg.
Package leaflet/ Patient Information Leaflet (PIL) affixed on bottle or included in shipper.

Therapeutic class: Antiretroviral medicine

Shelf life: 24 months

Storage temperature instructions: Do not store above 30°C

Material safety data sheet information (MSDS): No

Component of a KIT: No

Guidelines for use:
https://www.who.int/teams/globa l-hiv-hepatitis-and-stis-programmes/guidelines/hiv-guidelines

WHO Paediatric ARV dosing dashboard - https://paedsarvdosing.org/
Related Products